Related Experiment Video
Updated: Mar 30, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
[Alpha Fetoprotein-producing Lung Adenocarcinoma]
Kazuyuki Komori1, Toshiharu Tabata, Kimiaki Sato
1Department of Thoracic Surgery, Tohoku Pharmaceutical University Hospital, Sendai, Japan.
This study details a rare case of alpha fetoprotein (AFP)-producing lung adenocarcinoma in a 53-year-old man. The diagnosis was confirmed through pathological and immunohistochemical analysis of a resected tumor.
Area of Science:
- Oncology
- Pulmonology
- Pathology
Background:
- Lung adenocarcinoma is a common malignancy, but AFP production is an extremely rare subtype.
- Early detection and accurate diagnosis are crucial for effective lung cancer management.
Observation:
- A 53-year-old male presented with right pneumothorax, a solid upper lobe tumor (S3), and mediastinal lymphadenopathy.
- Initial imaging revealed a significant right pneumothorax and suspicious mediastinal lymph nodes.
Findings:
- Serum alpha fetoprotein (AFP) levels were markedly elevated at 223.0 ng/ml.
- Frozen section examination indicated a poorly differentiated adenocarcinoma.
- Pathological and immunohistochemical analyses confirmed the tumor as AFP-producing lung adenocarcinoma.
Implications:
- This case highlights the importance of considering rare tumor subtypes in differential diagnoses.
- Elevated AFP levels in lung cancer patients may indicate specific tumor characteristics.
- Further research into AFP-producing lung adenocarcinoma could improve diagnostic and therapeutic strategies.
More Related Videos
10:33Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018